Table 1.
Age and sex specific distribution of IOP (mm Hg) in all healthy Tehran Eye Study participants (n = 3833) and in healthy individuals without history of diabetes or hypertension (n = 3457)
| Age group (years) | Women Mean (SD) (n) | Men Mean (SD) (n) | All Mean (SD) (n) | |
| All healthy individuals | 10–19.9 | 14.1 (2.2) (566) | 13.6 (2.2) (503) | 13.9 (2.2) (1069) |
| 20–29.9 | 14.1 (2.1) (490) | 14.1 (2.5) (236) | 14.1 (2.2) (726) | |
| 30–39.9 | 14.6 (2.3) (413) | 14.4 (2.5) (246) | 14.6 (2.4) (659) | |
| 40–49.9 | 15.1 (2.6) (398) | 15.1 (2.7) (212) | 15.1 (2.7) (610) | |
| 50–59.9 | 15.0 (3.1) (233) | 14.8 (3.1) (175) | 14.9 (3.1) (408) | |
| 60–69.9 | 15.4 (2.9) (102) | 15.5 (3.3) (112) | 15.5 (3.1) (214) | |
| > = 70 | 14.9 (3.2) (65) | 15.3 (2.7) (82) | 15.1 (2.9) (147) | |
| Total | 14.5 (2.5) (2267) | 14.4 (2.7) (1566) | 14.5 (2.6) (3833) | |
| Healthy individuals without diabetes or hypertension | 10–19.9 | 14.1 (2.2) (562) | 13.6 (2.2) (501) | 13.9 (2.2) (1063) |
| 20–29.9 | 14.0 (2.1) (487) | 14.1 (2.5) (234) | 14.1 (2.3) (721) | |
| 30–39.9 | 14.6 (2.3) (393) | 14.4 (2.5) (236) | 14.5 (2.4) (629) | |
| 40–49.9 | 15.2 (2.6) (334) | 14.9 (2.8) (190) | 15.1 (2.7) (524) | |
| 50–59.9 | 14.7 (2.8) (172) | 14.8 (3.0) (142) | 14.8 (2.9) (314) | |
| 60–69.9 | 15.1 (2.6) (46) | 15.1 (3.1) (71) | 15.1 (2.9) (117) | |
| > = 70 | 14.2 (3.1) (26) | 15.4 (2.7) (63) | 15.1 (2.9) (89) | |
| Total | 14.4 (2.4) (2020) | 14.3 (2.6) (1437) | 14.4 (2.5) (3457) |